Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients
View ORCID ProfileSimeng Lin, View ORCID ProfileNicholas A Kennedy, Aamir Saifuddin, Diana Muñoz Sandoval, View ORCID ProfileCatherine J Reynolds, Rocio Castro Seoane, Sherine H Kottoor, Franziska P Pieper, Kai-Min Lin, David K. Butler, View ORCID ProfileNeil Chanchlani, Rachel Nice, View ORCID ProfileDesmond Chee, View ORCID ProfileClaire Bewshea, Malik Janjua, View ORCID ProfileTimothy J McDonald, View ORCID ProfileShaji Sebastian, View ORCID ProfileJames L Alexander, Laura Constable, James C Lee, View ORCID ProfileCharles D Murray, View ORCID ProfileAilsa L Hart, View ORCID ProfilePeter M Irving, View ORCID ProfileGareth-Rhys Jones, View ORCID ProfileKlaartje B Kok, View ORCID ProfileChristopher A Lamb, View ORCID ProfileCharlie W Lees, View ORCID ProfileDaniel M Altmann, View ORCID ProfileRosemary J Boyton, View ORCID ProfileJames R Goodhand, View ORCID ProfileNick Powell, View ORCID ProfileTariq Ahmad, Contributors of the CLARITY IBD study
doi: https://doi.org/10.1101/2021.11.10.21266168
Simeng Lin
1Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
2Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, UK
MBChBNicholas A Kennedy
1Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
2Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, UK
PhDAamir Saifuddin
3Department of Gastroenterology, St Marks Hospital and Academic Institute, London, UK
4Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
BM.BChDiana Muñoz Sandoval
5Department of Infectious Disease, Imperial College London, London, UK
PhDCatherine J Reynolds
5Department of Infectious Disease, Imperial College London, London, UK
PhDRocio Castro Seoane
6Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
PhDSherine H Kottoor
4Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
PhDFranziska P Pieper
5Department of Infectious Disease, Imperial College London, London, UK
MScKai-Min Lin
5Department of Infectious Disease, Imperial College London, London, UK
PhDDavid K. Butler
5Department of Infectious Disease, Imperial College London, London, UK
MScNeil Chanchlani
1Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
2Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, UK
MBChBRachel Nice
2Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, UK
7Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
MScDesmond Chee
1Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
2Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, UK
MBBSClaire Bewshea
2Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, UK
MScMalik Janjua
1Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
2Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, UK
MBBSTimothy J McDonald
7Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
PhDShaji Sebastian
8IBD Unit, Department of Gastroenterology, Hull University Teaching Hospitals NHS Trust, Hull, UK
9Hull York Medical School, University of Hull, Hull, UK
MDJames L Alexander
4Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
10Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK
PhDLaura Constable
4Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
MResJames C Lee
11Department of Gastroenterology, Royal Free London NHS Foundation Trust, London, UK
12Genetic Mechanisms of Disease Laboratory, The Francis Crick Institute, London, UK
13Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK
PhDCharles D Murray
11Department of Gastroenterology, Royal Free London NHS Foundation Trust, London, UK
PhDAilsa L Hart
3Department of Gastroenterology, St Marks Hospital and Academic Institute, London, UK
PhDPeter M Irving
14Department of Gastroenterology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
15School of Immunology & Microbial Sciences, King’s College London, London, UK
MDGareth-Rhys Jones
16Department of Gastroenterology, Western General Hospital, NHS Lothian, Edinburgh, UK
17Centre for Inflammation Research, The Queen’s Medical Research Institute, The University of Edinburgh, Edinburgh, UK
Klaartje B Kok
18Department of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK
19Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK
PhDChristopher A Lamb
20Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
21Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK
PhDCharlie W Lees
16Department of Gastroenterology, Western General Hospital, NHS Lothian, Edinburgh, UK
22Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK
PhDDaniel M Altmann
6Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
PhDRosemary J Boyton
5Department of Infectious Disease, Imperial College London, London, UK
23Lung Division, Royal Brompton Hospital and Harefield Hospitals, London, UK
PhDJames R Goodhand
1Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
2Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, UK
MBBSNick Powell
4Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
10Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK
PhDTariq Ahmad
1Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
2Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, UK
DPhil
- Supplementary information[supplements/266168_file02.pdf]
Posted November 11, 2021.
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients
Simeng Lin, Nicholas A Kennedy, Aamir Saifuddin, Diana Muñoz Sandoval, Catherine J Reynolds, Rocio Castro Seoane, Sherine H Kottoor, Franziska P Pieper, Kai-Min Lin, David K. Butler, Neil Chanchlani, Rachel Nice, Desmond Chee, Claire Bewshea, Malik Janjua, Timothy J McDonald, Shaji Sebastian, James L Alexander, Laura Constable, James C Lee, Charles D Murray, Ailsa L Hart, Peter M Irving, Gareth-Rhys Jones, Klaartje B Kok, Christopher A Lamb, Charlie W Lees, Daniel M Altmann, Rosemary J Boyton, James R Goodhand, Nick Powell, Tariq Ahmad, Contributors of the CLARITY IBD study
medRxiv 2021.11.10.21266168; doi: https://doi.org/10.1101/2021.11.10.21266168
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients
Simeng Lin, Nicholas A Kennedy, Aamir Saifuddin, Diana Muñoz Sandoval, Catherine J Reynolds, Rocio Castro Seoane, Sherine H Kottoor, Franziska P Pieper, Kai-Min Lin, David K. Butler, Neil Chanchlani, Rachel Nice, Desmond Chee, Claire Bewshea, Malik Janjua, Timothy J McDonald, Shaji Sebastian, James L Alexander, Laura Constable, James C Lee, Charles D Murray, Ailsa L Hart, Peter M Irving, Gareth-Rhys Jones, Klaartje B Kok, Christopher A Lamb, Charlie W Lees, Daniel M Altmann, Rosemary J Boyton, James R Goodhand, Nick Powell, Tariq Ahmad, Contributors of the CLARITY IBD study
medRxiv 2021.11.10.21266168; doi: https://doi.org/10.1101/2021.11.10.21266168
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)